StockNews.com cut shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Get Rating) from a buy rating to a hold rating in a research note published on Friday. A number of other analysts have also recently issued reports on AMPH. Capital One Financial started coverage on Amphastar Pharmaceuticals in a research report on Friday, July 29th. They set […]
